Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03647930 · ClinicalTrials.gov registry record · NA
The Effect of Arista on Post-Operative Bleeding and Wound Drainage Following Mastectomy
A NA study of Seroma, sponsored by Memorial Health University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03647930: Completed NA study of Seroma, sponsored by Memorial Health University Medical Center.
NCT03647930 is a NA study of Seroma that has completed, run by Memorial Health University Medical Center. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03647930, a NA study of Seroma, has completed, sponsored by Memorial Health University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Study aim was to evaluate topical MPH on the risk of post-mastectomy seroma formation as measured by total drain output and total drain days.
Primary Outcome
Time to Drain Removal
Conditions Studied
Interventions
- DEVICE Microporous Polysaccharide Hemospheres (MPH)
Study Locations (1)
Georgia
- Memorial Health University Medical Center - Savannah
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2012-05-15 |
| Est. Completion | 2015-03-06 |
| Phase | NA |
What the finished NCT03647930 record still lists
NCT03647930 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Seroma appearing as the primary indexed condition, and to 1 intervention - of which Microporous Polysaccharide Hemospheres (MPH) is the first listed.
NCT03647930 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT03647930 about?
NCT03647930 is a clinical study titled "The Effect of Arista on Post-Operative Bleeding and Wound Drainage Following Mastectomy". Study aim was to evaluate topical MPH on the risk of post-mastectomy seroma formation as measured by total drain output and total drain days.
What is the current status of trial NCT03647930?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2012-05-15. Estimated completion is 2015-03-06.
What conditions does trial NCT03647930 study?
This clinical trial studies the following conditions: Seroma.
What interventions are being tested in trial NCT03647930?
The interventions under investigation include: Microporous Polysaccharide Hemospheres (MPH) (DEVICE).
Who is sponsoring clinical trial NCT03647930?
This trial is sponsored by Memorial Health University Medical Center, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03647930 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03647930's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI